Effects of component blood transfusion and whole blood transfusion on the incidence of non-hemolytic fever
10.3760/cma.j.issn.1008-6706.2019.13.017
- VernacularTitle: 成分输血与输全血对非溶血性发热发生情况的影响
- Author:
Yonghua DU
1
Author Information
1. Body Collection, the Center Blood Station of Datong, Datong, Shanxi 037008, China
- Publication Type:Journal Article
- Keywords:
Blood component transfusion;
Blood transfusion;
Non-hemolytic fever
- From:
Chinese Journal of Primary Medicine and Pharmacy
2019;26(13):1604-1606
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the effects of component blood transfusion and whole blood transfusion on the incidence of nonhemolytic fever(FNHTR).
Methods:A total of 384 patients who needed blood transfusion were treated from January 2015 to January 2017 in The Third People's Hospital of Datong.The patients were randomly divided into control group (n=192) and observation group(n=192) according to the digital table.The control group was treated with whole blood transfusion, and the observation group was treated with blood component therapy.The incidence of FNHTR was compared between the two groups.
Results:The incidence rates of FNHTR in the control group and the observation group with blood transfusion 1 time were 6.85% and 0.67%, respectively, which were significantly lower than those of the blood transfusion ≥2 times (23.91% and 7.14%), there were statistically significant differences between the two groups(χ2=10.455, 6.746, all P<0.05). The total incidence rate of FNHTR in the observation group was 2.08%, which was significantly lower than that in the control group(10.94%), the difference between the two groups was statistically significant(χ2=12.365, P<0.05).
Conclusion:The use of component blood transfusion in the course of clinical treatment can effectively reduce the incidence of FNHTR, effectively inhibit the incidence of blood transfusion related diseases, improve the safety of clinical treatment, the effect is remarkable, and is worthy of clinical promotion.
